Skip to content

Insider · CIK 0002018119

Ulrich Martin Fuhs

officer

Files at ALPN (ALPINE IMMUNE SCIENCES, INC.). First filing -, latest -.

In brief

Ulrich Martin Fuhs files SEC Form 4 as officer at ALPN (ALPINE IMMUNE SCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Ulrich Martin Fuhs has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 20, 2024ALPN
ALPINE IMMUNE SCIENCES, INC.
DDisposition to issuer
Common Stock
-22,820--7,300May 20, 2024
May 20, 2024ALPN
ALPINE IMMUNE SCIENCES, INC.
DDisposition to issuer
Common Stock
-7,300--0May 20, 2024
May 20, 2024ALPN
ALPINE IMMUNE SCIENCES, INC.
DDisposition to issuer
Stock Option (Right to buy)derivative
-52,180--0May 20, 2024
May 20, 2024ALPN
ALPINE IMMUNE SCIENCES, INC.
DDisposition to issuer
Stock Option (Right to buy)derivative
-28,700--0May 20, 2024
May 20, 2024ALPN
ALPINE IMMUNE SCIENCES, INC.
DDisposition to issuer
Stock Option (Right to buy)derivative
-14,600--0May 20, 2024
May 8, 2024ALPN
ALPINE IMMUNE SCIENCES, INC.
MOption exercise
Common Stock
+22,820$12.07$275k30,120May 10, 2024
May 8, 2024ALPN
ALPINE IMMUNE SCIENCES, INC.
MOption exercise
Stock Option (Right to buy)derivative
-22,820$0.00$052,180May 10, 2024

Questions about Ulrich Martin Fuhs

Answered from the filings on this page, as of the latest one.

Is Ulrich Martin Fuhs buying or selling?

Ulrich Martin Fuhs has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Ulrich Martin Fuhs's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ulrich Martin Fuhs has 0.

Where does Ulrich Martin Fuhs file Form 4?

Ulrich Martin Fuhs has filed Form 4 at ALPN (ALPINE IMMUNE SCIENCES, INC.) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Ulrich Martin Fuhs: insider trades and track record | InsiderTell